Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354010 · ClinicalTrials.gov registry record
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
A clinical trial of Sensorineural Hearing Loss, Bilateral, sponsored by Sensorion.
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT06354010 is a study of Sensorineural Hearing Loss, Bilateral that is actively recruiting participants, run by Sensorion. The registered enrollment target is 100 participants, above the 83-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (20% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06354010, a study of Sensorineural Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Sensorion.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
Conditions Studied
Interventions
- GENETIC Genotyping
- OTHER Audiological assessments
Study Locations (2)
Florida
- The University of South Florida Board of Trustees - Tampa
Other
- CHU Gui de Chauliac - Montpellier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06354010
The ClinicalTrials.gov registry entry for NCT06354010 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 83-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (20% higher). The listed sponsor is Sensorion, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sensorineural Hearing Loss, Bilateral appearing as the primary indexed condition, and to 2 interventions - of which Genotyping is the first listed.
NCT06354010 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Other.
Frequently Asked Questions
What is clinical trial NCT06354010 about?
NCT06354010 is a clinical study titled "Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis". The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
What is the current status of trial NCT06354010?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-06-14. Estimated completion is 2027-07.
What conditions does trial NCT06354010 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral.
What interventions are being tested in trial NCT06354010?
The interventions under investigation include: Genotyping (GENETIC), Audiological assessments (OTHER).
Who is sponsoring clinical trial NCT06354010?
This trial is sponsored by Sensorion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354010 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss, Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Otoferlin Gene-mediated Hearing Loss Natural History Study
RECRUITING
-
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
RECRUITING · Phase 1
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.